Until recently, plastic surgery was based on a simple principle: signs of aging were eliminated by excising skin, fat, fascia, and muscle tissue, followed by tightening of the remaining tissues. But what about now? What changes have occurred in the approach to rejuvenation?
Millions of botulinum toxin injections have been performed worldwide. However, not all of them were done with contraindications taken into account, and not all patients were satisfied with the results.
AbbVie has submitted an application to the FDA for the approval of TrenibotE — the first-in-class botulinum toxin type E. The product demonstrates a record-fast onset of action (8 hours) and a short duration of effect (2-3 weeks), which may change the approach to initial injections in patients who have previously avoided neurotoxins.
About the project
EstPortal.com (Aesthetic Portal) – is a professional resource dedicated to beauty. The project will be of interest to both beauty industry specialists and its connoisseurs. The aim of the project: to provide maximum time saving on search of necessary information for beauty industry specialists and site visitors.